CHPA Adopts Voluntary Guidelines for Caffeine-Containing Supplements

New guidelines to enhance transparency for consumers

Washington, D.C. (June 21, 2013)—The Consumer Healthcare Products Association (CHPA) Board of Directors approved voluntary labeling guidelines for caffeine-containing dietary supplements during the June 18 board meeting. This voluntary measure was taken in support of the Food and Drug Administration’s suggestion to food and dietary supplement manufacturers to include more information about caffeine on product labels.

“Over-the-counter medicines containing caffeine disclose its presence on the label with the amount in each dose in addition to including important cautionary statements.  These new guidelines will ensure equal transparency for our members’ dietary supplements, giving consumers the information they need to safely choose and use a dietary supplement,” CHPA Vice President of Regulatory & Scientific Affairs Barbara A. Kochanowski, Ph.D., said.

CHPA members marketing caffeine-containing dietary supplements agree to adopt voluntary guidelines addressing labeling, packaging, and promotion to ensure safe and responsible use of these products.

The guidelines include the following:

  • provide disclosure of total caffeine content (mg/serving)
  • provide information that should be included in labeling for a supplement containing >100 mg per serving (i.e., not intended for children less than 18 years of age or for caffeine-sensitive individuals, and pregnant or nursing women should talk to a healthcare professional before use); and
  • stipulate that caffeine-containing supplements should not be marketed, advertised, or promoted in combination with alcohol. 

A full description of the guidelines can be viewed here.

Contact: Jenni Terry, 202.429.9260

CHPA is the 132-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.